Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm
暂无分享,去创建一个
I. Rapado | J. Martínez-López | F. Gilsanz | S. Barrio | M. Gallardo | Alicia Arenas | R. Ayala | D. Rueda | A. Jiménez | E. Albízua | C. Burgaleta | J. Martínez‐López | Enriqueta Albízua | A. Arenas